[Psychosocial Effects in Patients with Penile Cancer : A Systematic Review]
Authors
Affiliations
Background: Psychological stress of patients with penile cancer arises from the cancer diagnosis itself and the treatment consequences. In addition, there is cancer-specific distress. There is the chance of cure in localized stages and in those with limited regional lymph node metastases but this requires surgery and often adjuvant chemotherapy. This systematic review gives a summary of the existing literature to date.
Materials And Methods: A critical database search using Medline was made in Ovid from 1946 to 2017, in the Cochrane Central Register of Controlled Trials (CENTRAL) and in the Web of Science from 1900 to 2017. This was complemented by a search of the World Health Organization's International Clinical Trials Registry Platform Search Portal and ClinicalTrials.gov. The reference lists of the included studies were manually searched for additional references.
Results: Selected studies (n = 10) addressed the psychosocial effects of penile cancer treatment on quality of life and sexual function. Due to the heterogeneity of the study designs only a narrative description of the results was possible. Defects or mutilation due to penile cancer cause psychological distress in a significant number of patients. Organ-sparing interventions have a positive impact on quality of life and sexual function.
Conclusion: The external genitals are a focus of sexual identity. Mutilating treatment causes significant distress but organ-sparing treatment and reconstruction positively influence quality of life.
Ashley L, Sutton K, Ju A, Edwards G, Pasli M, Bhatt A Front Oncol. 2023; 13:1271913.
PMID: 38023122 PMC: 10644775. DOI: 10.3389/fonc.2023.1271913.
Jakobsen J, Sorensen C, Krarup K, Jensen J BJUI Compass. 2022; 3(5):354-362.
PMID: 35950041 PMC: 9349586. DOI: 10.1002/bco2.159.
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study.
Fu L, Tian T, Yao K, Chen X, Luo G, Gao Y JMIR Public Health Surveill. 2022; 8(7):e34874.
PMID: 35793140 PMC: 9301560. DOI: 10.2196/34874.
Sakalis V, Campi R, Barreto L, Perdomo H, Greco I, Zapala L Eur Urol Open Sci. 2022; 40:58-94.
PMID: 35540709 PMC: 9079254. DOI: 10.1016/j.euros.2022.04.002.
Lebentrau S, Wakileh G, Schostak M, Schmid H, Suarez-Ibarrola R, Merseburger A Front Oncol. 2021; 11:759362.
PMID: 34912711 PMC: 8667688. DOI: 10.3389/fonc.2021.759362.